Gallic acid mediates tumor-suppressive effects on osteosarcoma through the H19-Wnt/β-catenin regulatory axis
Authors:
Open Access
- 4 January 2023
- journal article
- research article
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 39, 34-42
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82204990, 82272526)
This publication has 45 references indexed in Scilit:
- The emerging role of lncRNAs in cancerNature Medicine, 2015
- Medicinal Importance of Gallic Acid and Its Ester Derivatives: a Patent ReviewPharmaceutical Patent Analyst, 2015
- The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancerOncotarget, 2015
- Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patientsLiver International, 2015
- Gallic acid inhibits migration and invasion of SCC-4 human oral cancer cells through actions of NF-κB, Ras and matrix metalloproteinase-2 and -9Oncology Reports, 2014
- Wnt Pathway in Osteosarcoma, from Oncogenic to TherapeuticJournal of Cellular Biochemistry, 2014
- Inhibition of Melanogenesis by Gallic Acid: Possible Involvement of the PI3K/Akt, MEK/ERK and Wnt/β-Catenin Signaling Pathways in B16F10 CellsInternational Journal of Molecular Sciences, 2013
- Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activityToxicology and Applied Pharmacology, 2013
- The anthocyanin metabolites gallic acid, 3-O -methylgallic acid, and 2,4,6-trihydroxybenzaldehyde decrease human colon cancer cell viability by regulating pro-oncogenic signalsMolecular Carcinogenesis, 2012
- Cytoplasmic Localization of β-Catenin is a Marker of Poor Outcome in Breast Cancer PatientsCancer Epidemiology, Biomarkers & Prevention, 2010